Answers are grounded in this paper and cite their sources.
Comprehensive review details molecular heterogeneity and emerging therapeutics in FGFR3-related short-limb skeletal dysplasias, highlighting targeted biological pathways for clinical intervention.
This book discusses achondroplasia and other FGFR3-related short limb dysplasias, their molecular heterogeneity, and therapeutic approaches. Achondroplasia is dominantly inherited and one ...
No takes yet. Share an insight, caveat, or question.
Sanjeeva et al. (2018) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: